Cargando…

Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations

Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dohayan, Nora D, Al-Batniji, Fatma, Alotaibi, Hammam A, Elbaage, Abdulaziz T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780955/
https://www.ncbi.nlm.nih.gov/pubmed/35103179
http://dx.doi.org/10.7759/cureus.20603
_version_ 1784637969907318784
author Al-Dohayan, Nora D
Al-Batniji, Fatma
Alotaibi, Hammam A
Elbaage, Abdulaziz T
author_facet Al-Dohayan, Nora D
Al-Batniji, Fatma
Alotaibi, Hammam A
Elbaage, Abdulaziz T
author_sort Al-Dohayan, Nora D
collection PubMed
description Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with the presence of antiphospholipid antibodies (aPL) like antibodies to beta-2-glycoprotein I (B-2-GPI) and anticardiolipin (aCL). The disease could be classified into primary APS in the absence of an underlying disease or secondary APS occurring secondary to autoimmune diseases, infections, malignancies, and sometimes medication use. In the absence of clinical manifestations of APS, transient non-thrombogenic antiphospholipid antibodies are seen more commonly in children, predominantly after childhood infections. Cases with clinical manifestations of APS associated with different types of infections have been reported in the literature to keep track of potential triggering causes and take measures to prevent or treat the disease manifestations. This case documents the case of hepatitis-A as a triggering viral infection, causing secondary APS in a child.
format Online
Article
Text
id pubmed-8780955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87809552022-01-30 Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations Al-Dohayan, Nora D Al-Batniji, Fatma Alotaibi, Hammam A Elbaage, Abdulaziz T Cureus Ophthalmology Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with the presence of antiphospholipid antibodies (aPL) like antibodies to beta-2-glycoprotein I (B-2-GPI) and anticardiolipin (aCL). The disease could be classified into primary APS in the absence of an underlying disease or secondary APS occurring secondary to autoimmune diseases, infections, malignancies, and sometimes medication use. In the absence of clinical manifestations of APS, transient non-thrombogenic antiphospholipid antibodies are seen more commonly in children, predominantly after childhood infections. Cases with clinical manifestations of APS associated with different types of infections have been reported in the literature to keep track of potential triggering causes and take measures to prevent or treat the disease manifestations. This case documents the case of hepatitis-A as a triggering viral infection, causing secondary APS in a child. Cureus 2021-12-22 /pmc/articles/PMC8780955/ /pubmed/35103179 http://dx.doi.org/10.7759/cureus.20603 Text en Copyright © 2021, Al-Dohayan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Al-Dohayan, Nora D
Al-Batniji, Fatma
Alotaibi, Hammam A
Elbaage, Abdulaziz T
Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title_full Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title_fullStr Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title_full_unstemmed Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title_short Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
title_sort hepatitis-a infection-induced secondary antiphospholipid syndrome with neuro-ophthalmological manifestations
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780955/
https://www.ncbi.nlm.nih.gov/pubmed/35103179
http://dx.doi.org/10.7759/cureus.20603
work_keys_str_mv AT aldohayannorad hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations
AT albatnijifatma hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations
AT alotaibihammama hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations
AT elbaageabdulazizt hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations